These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


106 related items for PubMed ID: 2480314

  • 1. Growth of hemopoietic cells after incubation with VP 16-213.
    Schulze E, Hofmann U, Woetzel M, Helbig W.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(3-4):591-6. PubMed ID: 2480314
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Cumulative chemotherapy increases mafosfamide toxicity for normal progenitor cells in AML patients: rationale for cryopreserving adapted-dose purged marrow early in first complete remission.
    Martin H, Bruecher J, Claudé R, Hoelzer D.
    Bone Marrow Transplant; 1993 Nov; 12(5):495-9. PubMed ID: 8298560
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Growth characteristics of marrow hematopoietic progenitor/precursor cells from patients on a phase I clinical trial with purified recombinant human granulocyte-macrophage colony-stimulating factor.
    Broxmeyer HE, Cooper S, Williams DE, Hangoc G, Gutterman JU, Vadhan-Raj S.
    Exp Hematol; 1988 Aug; 16(7):594-602. PubMed ID: 3260558
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effect of chemotherapy for acute myelogenous leukemia on hematopoietic and fibroblast marrow progenitors.
    Carlo-Stella C, Tabilio A, Regazzi E, Garau D, La Tagliata R, Trasarti S, Andrizzi C, Vignetti M, Meloni G.
    Bone Marrow Transplant; 1997 Sep; 20(6):465-71. PubMed ID: 9313879
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Efficacy of a combined treatment with ASTA-Z 7654 and VP16-213 in vitro in eradicating clonogenic tumor cells from human bone marrow.
    De Fabritiis P, Pulsoni A, Sandrelli A, Simone F, Amadori S, Meloni G, Mandelli F.
    Bone Marrow Transplant; 1987 Oct; 2(3):287-98. PubMed ID: 3502785
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effect of retinoic acid on the clonal growth of childhood myeloid and lymphoid leukemias: a pediatric oncology group study.
    Findley HW, Steuber CP, Ruymann FB, Culbert S, Ragab AH.
    Exp Hematol; 1984 Nov; 12(10):768-73. PubMed ID: 6334611
    [Abstract] [Full Text] [Related]

  • 18. Hemotoxicity by prolonged etoposide administration to mice can be prevented by simultaneous growth factor therapy.
    de Haan G, Engel C, Dontje B, Loeffler M, Nijhof W.
    Cancer Res; 1995 Jan 15; 55(2):324-9. PubMed ID: 7529132
    [Abstract] [Full Text] [Related]

  • 19. Preclinical studies of the combination of mafosfamide (Asta-Z 7654) and etoposide (VP-16-213) for purging leukemic autologous marrow.
    Tamayo E, Hervé P.
    Exp Hematol; 1988 Feb 15; 16(2):97-101. PubMed ID: 3276544
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.